Miro Viitala
Publications
- A form of inherited hyperferritinemia associated with bi-allelic pathogenic variants of STAB1 (2023)
- American Journal of Human Genetics
(A1 Refereed original research article in a scientific journal) - Makrofagit älykkäästi mukaan syövän hoitoon (2023)
- Duodecim
(A2 Refereed review article in a scientific journal ) - Re-educating macrophages to activate antitumor immunity: One Clever Immunotherapy (2023) Viitala Miro
(G5 Article dissertation ) - Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial (2021)
- Clinical Cancer Research
(A1 Refereed original research article in a scientific journal) - Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8(+) T-cell Response against Immunosuppressive Tumors (2019)
- Clinical Cancer Research
(A1 Refereed original research article in a scientific journal) - Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice (2018)
- Frontiers in immunology
(A1 Refereed original research article in a scientific journal) - Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice (2018)
- Arteriosclerosis, Thrombosis, and Vascular Biology
(A1 Refereed original research article in a scientific journal) - High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer (2016)
- Journal of Molecular Biochemistry
(A1 Refereed original research article in a scientific journal)